Terri B. Sebree

2020

In 2020, Terri B. Sebree earned a total compensation of $1.1M as President at Zynerba Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$209,660
Option Awards$428,858
Salary$450,883
Other$26,251
Total$1,115,652

Sebree received $450.9K in salary, accounting for 40% of the total pay in 2020.

Sebree also received $209.7K in non-equity incentive plan, $428.9K in option awards and $26.3K in other compensation.

Rankings

In 2020, Terri B. Sebree's compensation ranked 8,155th out of 13,090 executives tracked by ExecPay. In other words, Sebree earned more than 37.7% of executives.

ClassificationRankingPercentile
All
8,155
out of 13,090
38th
Division
Manufacturing
3,459
out of 5,621
39th
Major group
Chemicals And Allied Products
1,396
out of 2,254
38th
Industry group
Drugs
1,216
out of 1,954
38th
Industry
Pharmaceutical Preparations
904
out of 1,459
38th
Source: SEC filing on April 21, 2021.

Sebree's colleagues

We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2020.

2020

Armando Anido

Zynerba Pharmaceuticals

Chief Executive Officer

2020

James Fickenscher

Zynerba Pharmaceuticals

Chief Financial Officer

News

You may also like